IPO registrations (S-1, F-1) · Registrants

Vaneltix Pharma, Inc.

SEC CIK

932352 · filings on EDGAR ↗

Name on the registration

Urigen Pharmaceuticals, Inc.

Former names

Urigen Pharmaceuticals, Inc. (2007–2020); VALENTIS INC (1999–2007); MEGABIOS CORP (1997–1999)

Registration

Form S-1, first filed 1997-07-31, last 2015-02-11; 3 initial registrations, 5 amendments

Outcome

Final prospectus filed 1997-09-16; declared effective 2007-06-11; withdrawal requested 2015-05-04

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

317 GEORGE STREET, SUITE 400, New Brunswick, NJ 08901

EIN

94-3156660

EDGAR entity type

operating

Insiders and CEO pay

Vaneltix Pharma, Inc. on the corporate pages

Offering terms

Proposed price range

$11.00–$13.00 per share (S-1/A filed 1997-09-11)

Final price

$12.00 per share, within the range (424B4 filed 1997-09-16, an initial public offering)

Shares sold

2,500,000

Gross proceeds

$30,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol MBIO

Lead underwriters

Montgomery Securities (755,000 shares); Hambrecht & Quist (755,000 shares)

Syndicate

BT Alex. Brown (90,000); Cowen (90,000); Goldman Sachs (90,000); Lehman Brothers (90,000); PaineWebber (90,000); Robertson Stephens (90,000); UBS (90,000); Cruttenden Roth Incorporated (45,000); Furman Selz LLC (45,000); Genesis Merchant Group Securities (45,000); Hampshire Securities Corporation (45,000); Pacific Growth Equities, Inc (45,000); Punk, Ziegel & Company, L.P (45,000); Raymond James (45,000); H.C. Wainwright (45,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Form D issuer: Vaneltix Pharma, Inc. EXACT (CIK (EXACT))
• SEC filer: Urigen Pharmaceuticals, Inc. EXACT (CIK (EXACT))
• Person page: Reinaldo M Diaz Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 12

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.